Supplement F: Laboratory Guidance

Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS) Version 2/3*

printer friendly version[480KB, 32 pages]

NOTICE

Since 2004, there have not been any known cases of SARS reported anywhere in the world. The content in this Web site was developed for the 2003 SARS epidemic. But, some guidelines are still being used. Any new SARS updates will be posted on this Web site.

Contents of this Section

Title	Section PDF
Summary	printer friendly version[53KB, 2 pages]
I. Rationale and Goals	printer friendly version[47KB, 1 page]
II. Lessons Learned	printer friendly version[46KB, 1 page]
III. Diagnostic Assays	printer friendly version[55KB, 2 pages]
IV. CDC’s Laboratory Diagnostics Plan	printer friendly version[87KB, 4 pages]
Appendix F1: Proficiency Testing for Public Health Laboratories Performing SARS-CoV EIA and RT-PCR Diagnostics	printer friendly version[62KB, 1 page]
Appendix F2: SARS-CoV Specimen Testing Guidelines: RT-PCR and Serology	printer friendly version[75KB, 4 pages]
Appendix F3: Guidelines for Clinicians: The Consent Process for SARS-CoV RT-PCR and EIA Testing at CDC and Public Health Laboratories	printer friendly version[67KB, 2 pages]
Appendix F4: Guidelines for Collecting Specimens from Potential SARS Patients	printer friendly version[60KB, 2 pages]
Appendix F5: Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with SARS-CoV	printer friendly version[89KB, 3 pages]
Appendix F6: Guidelines for Medical Surveillance of Laboratory Personnel Working with SARS-CoV	printer friendly version[71KB, 3 pages]
Appendix F7: Fact Sheet for Clinicians: Interpreting SARS-CoV Test Results from CDC and Other Public Health Laboratories	printer friendly version[108KB, 4 pages]
Appendix F8: Guidelines for Laboratory Diagnosis of SARS-CoV Infection	printer friendly version[49KB, 1 page]

Footnote *

This version of Supplement F includes additional guidance on the types of specimens to collect for SARS-CoV testing and the optimal timing for collection. Three new appendices have been included:

Appendix F3: Guidelines for Clinicians: The Consent Process for SARS-CoV RT-PCR and EIA Testing at CDC and Public Health Laboratories
Appendix F6: Guidelines for Medical Surveillance of Laboratory Personnel Working with SARS-CoV
Appendix F8: Guidelines for Laboratory Diagnosis of SARS-CoV Infection

Top of Page

Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more

This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.

Contact Us:

Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333
800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
8am-8pm ET/Monday-Friday
Closed Holidays
cdcinfo@cdc.gov